EPISODE · Dec 31, 2021 · 29 MIN
Teprotumumab and Thyroid Eye Disease
from Experts InSight
Drs. Alison Watson and Seanna Grob review recent data on teprotumumab, the only FDA-approved therapy for thyroid eye disease. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
Embed this episode
NOW PLAYING
Teprotumumab and Thyroid Eye Disease
0:00
29:59
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Experts InSight?
This episode is 29 minutes long.
When was this Experts InSight episode published?
This episode was published on December 31, 2021.
Can I download this Experts InSight episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!